Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +45.01%
#2 Pons Pons +37.09%
#3 Mubarak Mubarak +36.45%
#4 Starpower Starpower +34.73%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +31.89%
#6 Bitway Bitway +31.78%
#7 TENDIES TENDIES +25.97%
#8 SkyAI SkyAI +25.15%
#9 Ocean Protocol Ocean Protocol +24.85%
#10 StonkBroker StonkBroker +21.30%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Elevation Oncology, Inc. Elevation Oncology, Inc.

Elevation Oncology, Inc.

ELEV
Clasificación en acciones #29358
Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company... Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company operating in the United States, committed to developing targeted cancer therapies for patients with specific genetic profiles. Its leading drug candidate is seribantumab, an anti-HER3 monoclonal antibody currently being evaluated in the Phase II CRESTONE trial. This study focuses on treating advanced solid tumors that harbor a neuregulin-1 fusion. The company was established in 2019 and is headquartered in New York, New York.
Precio por acción
$0.365
Última sincronización: 2025-08-01
Capitalización bursátil
$21.54M
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Elevation Oncology, Inc. (ELEV)

Categoría

Healthcare
Ganancias de Elevation Oncology, Inc. (ELEV)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Elevation Oncology, Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Elevation Oncology, Inc. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH